The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways
Edward M. Conway(University of British Columbia), Gregor Theilmeier(Scripps Research Institute), D Collen(VIB-KU Leuven Center for Cancer Biology), Peter W. Hellings(KU Leuven), Saskia Pollefeyt(Vlaams Instituut voor Biotechnologie), Astrid De Vriese(Vlaams Instituut voor Biotechnologie), Marlies Van de Wouwer(Vlaams Instituut voor Biotechnologie), Jeffrey I. Weitz(McMaster University Medical Centre), Paul Schaeffer(Universidad La Salle), Jean‐Marc Herbert(Sanofi (France)), Hartmut Weiler(Medical College of Wisconsin), Kerstin Jurk, Hugo Van Aken(University Hospital Münster)
Cited by 349
Related Papers
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k